Deep Track Capital, LP 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 08:44 am Purchase | 2025-03-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 5,500,000 7.210% | 1,375,000 (+33.33%) | Filing |
| 2025-02-14 4:31 pm Purchase | 2025-02-07 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 4,125,000 5.440% | 1,125,000 (+37.50%) | Filing |
| 2025-02-14 08:42 am Purchase | 2024-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 3,000,000 4.240% | 2,170 (+0.07%) | Filing |
| 2024-02-14 08:51 am Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,997,830 6.180% | 280,659 (+10.33%) | Filing |
| 2023-02-24 4:13 pm Purchase | 2023-02-16 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,717,171 5.750% | 450,602 (+19.88%) | Filing |
| 2023-02-14 08:50 am Sale | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,266,569 4.810% | -169,595 (-6.96%) | Filing |
| 2022-06-10 4:02 pm Purchase | 2022-06-01 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,436,164 5.190% | 2,436,164 (New Position) | Filing |